Majidova, N. (2025) “Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)”, Turkish Journal of Gastroenterology, 36(5), pp. 293–301. doi: 10.5152/tjg.2025.24784.